Development and Preliminary Trial of a Brief, Portable Health Intervention for Rural Sexual Minority Emerging Adults (Project LEAP)
27 de agosto de 2020 actualizado por: Yale University
The purpose of this study is to test the feasibility of writing interventions specifically designed for lesbian, gay, and bisexual (LGB) emerging adults (ages 18-29) that are aimed at improving the outcomes: depression, suicidality, substance abuse and HIV risk behaviors.
Descripción general del estudio
Estado
Terminado
Intervención / Tratamiento
Descripción detallada
This study is considered the third part ("Phase 3") of a larger study where parts one and two were designed to utilize elicitation focus groups to develop effective intervention materials (Phase 1) and then refine the developed materials through structured interviews (Phase 2).
Phase 3 will test feasibility and assess early signs of efficacy of writing interventions.
To do this, participants will be randomized to one of three arms (one arm will serve as control).
Those that choose to participate will be asked to complete outcome measures (depressive symptoms, suicidality, use of alcohol and illicit drugs, HIV risk behavior) and measures of proposed mediators (self-reported and biological stress, behavioral and emotional self-regulation) and moderators (e.g., social support, identity centrality) at baseline, post-intervention, and three-month follow-up.
In addition, structured interviews with 15 intervention participants will be used to refine study procedures as the investigators scale up this intervention for a future randomized controlled trial (RCT).
Tipo de estudio
Intervencionista
Inscripción (Actual)
108
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Connecticut
-
New Haven, Connecticut, Estados Unidos, 06520
- Yale University
-
-
Massachusetts
-
Worcester, Massachusetts, Estados Unidos, 01610
- College of the Holy Cross
-
-
Tennessee
-
Johnson City, Tennessee, Estados Unidos, 37614
- East Tennessee State University
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años a 29 años (Adulto)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Self-identify as lesbian, gay, or bisexual
- Live in Washington county, Tennessee (TN), or any of its 6 contiguous counties in northeastern TN
- Have personal Internet access
- Hair at least 2cm in length
Exclusion Criteria:
- Failure to meet inclusion criteria
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Expressive Writing (EW)
Expressive Writing (EW) prompts individuals to write about personally stressful events, potentially enabling cognitive processing of unresolved, psychological and physiological stressors.
|
The EW intervention will utilize the procedures piloted earlier with gay and bisexual male college students in urban and rural regions of the US.
In this condition, participants will be instructed to write for 20 minutes across three consecutive days in a free-form manner about the most stressful or traumatic LGB-related event that they have encountered.
|
|
Experimental: Self-Affirmation (SA)
Self-Affirmation (SA) interventions prompt individuals to write advice to a (hypothetical) similarly stigmatized person regarding how best to cope with stigma-related stress.
By affirming one's own stigmatized identity through the process of helping another similarly stigmatized person.
|
The SA intervention will ask participants to read a brief description, over the course of 3 consecutive days, of a (hypothetical) LGB youth who is facing minority stress.
Each day's description will contain a different LGB youth facing a different stigma-related stressor derived from Phase 1 and 2 interviews.
Participants will then be asked to write a letter for 20 minutes to advise the LGB youth how best to cope with minority stress drawing on their personal experiences.
|
|
Comparador de placebos: Control
Participants randomly assigned to the control condition will be asked to write about what they have done since waking up that morning for 20 minutes across 3 consecutive days.
|
Participants randomly assigned to the control condition will be asked to write about what they have done since waking up that morning for 20 minutes across 3 consecutive days.
This control matches the time and activity of the EW and SA arms and has been implemented across dozens of EW and SA studies.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Depression.
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Depression will be measured using the Center for Epidemiological Studies -- Depression Scale (CESD).
An overall depression score is computed as the sum of 20 items, with items 3, 11, 14, and 16 reversed.
In cases with internally missing data (items not answered), the sums are computed after imputation of the missing values: # items on scale / # actually answered, multiplied by the sum obtained from the answered items.
A range of 0-60, with higher scores indicating more depressive symptomatology during the past week.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Psychological Distress.
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Psychological Distress will be measured using the Brief Symptom Inventory (BSI).
The BSI consists of 18 items scored 0-4.
Items are averaged to yield a final score of 0-4.
The higher the score, the greater the psychological distress.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Anxiety.
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Anxiety will be measured using the Beck Anxiety Inventory (BAI).
The BAI total score is reported, which is the sum of all 21 items; with no subscales.
The range of scores is 0-63, with higher scores indicating higher anxiety.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Suicidality - Suicidal Ideation.
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Suicidal ideation will be measured using the Suicidal Ideation Attributes Scale (SIDAS) .
Total SIDAS scores are calculated as the sum of the five items, with controllability reverse scored (10=0, 9=1, …, 0=10).
Total scores range from 0 to 50.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Alcohol Use.
Periodo de tiempo: Baseline, Post Intervention, 3 Months
|
Alcohol use in participants will be assessed using the Alcohol Use Disorders Identification (AUDIT) instrument.
The AUDIT consists of 10 items.
Each of the questions has a set of responses to choose from, and each response has a score ranging from 0 to 4. All response scores should be added and recorded as "Total".
Total scores of 8 or more are recommended as indicators of hazardous and harmful alcohol use, as well as possible alcohol dependence.
(A cut-off score of 10 will provide greater specificity but at the expense of sensitivity.)
The score range is 0-40.
Higher scores indicate greater hazardous drinking.
|
Baseline, Post Intervention, 3 Months
|
|
Change in Drug Use.
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
The Short Inventory of Problems-Modified for Drug Use (SIP-DU) is a 15-item scale that asks respondents to rate each item on a dichotomous scale ("No" = 0, "Yes" = 1).
Total score reported, which is the sum of all items; no subscales: Range 0-15, higher scores indicate greater problems with drug use.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Suicidal Intent
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Suicidal intent will be assessed using a single item that asks: Within the last 3 months/past week, have you seriously considered attempting suicide?
[yes/no] Number of participants who reported suicidal intent is reported.
Originally titled "Change in Suicidality - Suicidal Thoughts".
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Attempted Suicide
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Suicide attempts will be assessed using a single item that asks: Within the last past 3 months/past week, have you actually attempted suicide?
[yes/no].
Reported are the number of participants who reported that they had attempted suicide.
Original title: "Change in Suicidality: Suicide Attempts".
|
Baseline, Post Intervention (day 5), and 3 Months.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Self Injury.
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Self injury behaviors will be assessed with the item that asks: How many times in the past 3 months/past week have you engaged in self-harm behavior (e.g., cutting, biting, burning, hitting self) with the intent of harming, but not killing, yourself?
Reported are the frequency of self-harm behaviors/self-injury reported by participants.
Original title: "Change in Self Injury".
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Rumination
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Rumination will be assessed using the Ruminative Response Scale - Brooding Subscale (RRS).
This scale is modified from the original measure where only items 5, 10, 13, 15 and 16 are used.
Each item is scored by respondents on a scale of 1 to 4. To get the overall score, the 5 items are summed; total scores range from 5-20, with higher scores indicating greater brooding and rumination (related to depression) in an individual.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Perceived Support
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Perceived social support is measured using the Multidimensional Scale of Perceived Social Support (MSPSS).
The MSPSS is a 12 item instrument that uses a scale 1-7 to rate each item.
The scoring is done by taking the average of the items- therefore a score of 7 indicates the highest level of perceived social support.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Hopelessness
Periodo de tiempo: Baseline, Post Intervention, 3 Months
|
Hopelessness will be measured using the Beck Hopelessness Scale (BHS).
The BHS is a 20-item dichotomous scale ("No" = 0, "Yes" = 1).
Items 1, 3, 5, 6, 8, 10, 13, 15 and 19 are reverse-scored.
The total score is out of 20, where 20 would be the highest score and considered a negative indicator of hopelessness.
|
Baseline, Post Intervention, 3 Months
|
|
Lesbian, Gay, Bisexual (LGB) Identity
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
LGB identity will be measured using the 'LGB Identity Centrality' instrument.The measure consists of 4 items that are rated on a scale of 1-7.
The summed scores have a range of 4-28 and the higher score would indicate a stong agreement (positive) with the centrality of one's LGB identity.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Cortisol
Periodo de tiempo: 1 and 4 months post baseline.
|
Participants will provide 50-100 hair strands (at least 2 cm in length) to be used to determine levels of stress based on the cortisol levels found in the analyses of the hair provided.
|
1 and 4 months post baseline.
|
|
Change in Stress
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Stress will be assessed using the Perceived Stress Scale (PSS).
Participants were asked to respond to the 14-item version.
Participants respond to each item on a 0-4 scale and scores are obtained by reversing responses to the 7 positively stated items (items 4,5,6,7,9,10, & 13), and then summing across all scale items.
Range = 0-56.
Higher scores indicating higher perceived stress.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Impulsiveness Total Score
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Impulsiveness will be assessed using the Barratt Impulsiveness Scale (BIS).
The BIS is a 30 item questionnaire that uses a 1-4 rating scale per item.
The 30-item self-report questionnaire, can yield a total score where the range is 30-120.
The highest score indicates the greatest the level of impulsiveness.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Impulsiveness- Attentional
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Impulsiveness will be assessed using the Barratt Impulsiveness Scale (BIS).
The BIS is a 30 item questionnaire that uses a 1-4 rating scale per item.
The 30-item self-report questionnaire, can yield a total score, as well as three factors: attentional (6, 5, 9, 11, 20, 24, 26, 28; motor (2, 3, 4, 16, 17, 19, 21, 22, 23, 25, 30); non-planning (1, 7, 8, 10, 12, 13, 14, 15, 18, 27, 29).
The attentional scale has a range of 8-32, the greater the value, the greater the level of attentional impulsiveness.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Impulsiveness- Motor
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Impulsiveness will be assessed using the Barratt Impulsiveness Scale (BIS-11).
The BIS-11 is a 30 item questionnaire that uses a 1-4 rating scale per item.
The 30-item self-report questionnaire, can yield a total score, as well as three factors: attentional (6, 5, 9, 11, 20, 24, 26, 28; motor (2, 3, 4, 16, 17, 19, 21, 22, 23, 25, 30); non-planning (1, 7, 8, 10, 12, 13, 14, 15, 18, 27, 29).
The motor scale has a range of 11-44, the greater the value, the greater the level of motor impulsiveness.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Impulsiveness- Non-Planning
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Impulsiveness will be assessed using the Barratt Impulsiveness Scale (BIS-11).
The BIS-11 is a 30 item questionnaire that uses a 1-4 rating scale per item.
The 30-item self-report questionnaire, can yield a total score, as well as three factors: attentional (6, 5, 9, 11, 20, 24, 26, 28; motor (2, 3, 4, 16, 17, 19, 21, 22, 23, 25, 30); non-planning (1, 7, 8, 10, 12, 13, 14, 15, 18, 27, 29).
The non-planning scale has a range of 11-44, the greater the value, the greater the level of non-planning impulsiveness.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Risk Taking
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Risk taking impulse will be assessed using the Columbia Card Task.
Participants are presented with 32 face-down cards.
Some of these cards are "gain cards" (which add either +10 or +30 points to the participant's total score) and some of these cards are "loss cards" (which subtract either -250 or -750 points from the participant's total score).
On each trial, the participant may turn over as many cards as desired until a loss card is encountered or the participant chooses to not turn over any more cards.
As a participant turns over more cards, the probability of encountering a loss card increases.
Therefore, turning over more cards constitutes greater risk taking.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Minority Stress (Rejection)
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
To assess rejection as a form of minority stress, the Gay-Related Rejection Sensitivity Scale (GRRS) will be used.The Gay-related rejection sensitivity scale was adapted for this study to be gender-inclusive and has 12 items.
Scale range 1-36, where higher scores indicate greater rejection sensitivity based on one's sexual orientation (worse outcome).
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Parental Attitudes
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
The participant's perception of their parent's attitudes towards their sexual orientation are assessed using the Parental Attitudes Toward Child's Sexual Orientation.
This tool has 4 items- 2 that deal with mother/parent 1/closest female guardian, 2 that deal with father/parent 2/closest male guardian.
The second item for each parent asks about their attitude towards the respondent's sexual orientation on a scale from 1 (completely tolerant and accepting) to 7 (completely hostile and rejecting).
Scores for maternal and paternal attitude should be averaged for each participant.
The score has a range from 1-7, where higher scores indicate greater rejection from parents (worse outcome).
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Outness
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Participants openness about one's sexual orientation will be assessed using the Outness Inventory (OI).
A respondent is asked to rate how open they are with various people in society (from family to strangers) on an 11 item questionnaire.
The scale for responding is 0-7- where 7 indicates that a person is completely open with their sexual orientation status.
The scale score is obtained by averaging the 11 items for a score range of 0-7, where higher scores indicate more openness about respondents' sexual orientation in different domains of their lives/different people.
0 indicates that an item does not apply/ there is no such group of people/person in the respondents' life.
A score of 7 would indicate that one is completely open or "out" with respect to sexual orientation.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Internalized Homophobia
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Internalized homophobia in participants will be assessed using the Internalized Homophobia Scale (IHS).
The IHS score is obtained by averaging the scores across the 9 items (rather than summing).
Range is 1-4, with higher scores indicating higher internalized stigma related to one's sexual orientation.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Discrimination - 9 Items (Part 1)
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Everyday discrimination experienced by participants will be measured using the Everyday Discrimination - Sexual Orientation (EDSO) Part 1. Part 1 is a 9 item inventory where respondents rate statements on a scale of 1-6.
The scale has a summed total score ranging from 9-54, higher scores indicate higher discrimination.
The higher the score, the greater the feeling that one is discriminated against for one's sexual orientation.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Discrimination - Item 1 (Part 2)
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Everyday discrimination experienced by participants will be measured using the Everyday Discrimination - Sexual Orientation (EDSO) Part 2. Part 2 is a 2 item inventory where respondents rate statements on a scale of 0-3. The lower the score, the less the feeling that one is discriminated against overall for one's sexual orientation. Item 1: Overall, how much has discrimination based on your sexual orientation interfered with you having a full and productive life? |
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Discrimination - Item 2 (Part 2)
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Everyday discrimination experienced by participants will be measured using the Everyday Discrimination - Sexual Orientation (EDSO) Part 2. Part 2 is a 2 item inventory where respondents rate statements on a scale of 0-3. The lower the score, the less the feeling that one is discriminated against overall for one's sexual orientation. Item 2: Overall, how much harder has your life been because of discrimination based on your sexual orientation? |
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Victimization
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Feelings of victimization are captured using the LGBT Victimization Experiences measure.
This questionnaire consists of 10 items.
The LGBT victimization scale is rated on a 0 "Never" to 3 "3+ times" scale with a total score range 0-30.
The total score reflects the amount of victimization one has experienced due to being known or thought to be LGBTQ.
Higher scores indicate more negative experiences.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Religious Affiliation
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Tolerance of one's sexual orientation through the lense of one's practiced religion is measured using a single question.
Respondents use a 1-7 scale to rate the question "How tolerant is your religion toward your sexual orientation?"-
where 7 indicates total rejection and hostility.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
|
Change in Religious Strain
Periodo de tiempo: Baseline, Post Intervention (day 5), and 3 Months.
|
Religious Strain Scale total score obtained by reverse scoring items 1-7 and then summing across the 20 items (range 0-60), higher scores indicate greater religious strain.
|
Baseline, Post Intervention (day 5), and 3 Months.
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Colaboradores
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
27 de octubre de 2017
Finalización primaria (Actual)
1 de enero de 2019
Finalización del estudio (Actual)
27 de junio de 2019
Fechas de registro del estudio
Enviado por primera vez
25 de julio de 2018
Primero enviado que cumplió con los criterios de control de calidad
19 de noviembre de 2018
Publicado por primera vez (Actual)
23 de noviembre de 2018
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
28 de agosto de 2020
Última actualización enviada que cumplió con los criterios de control de calidad
27 de agosto de 2020
Última verificación
1 de agosto de 2020
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 1512016952
- 1R21MH113860-01 (Subvención/contrato del NIH de EE. UU.)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Sí
Descripción del plan IPD
De-identified individual participant data for all primary and secondary outcome measures will be made available.
Marco de tiempo para compartir IPD
Data will be available 12 months after study completion for three years.
Criterios de acceso compartido de IPD
Data access requests from qualified academic investigators for non-commercial research interests will be reviewed by study investigators.
Requestors will be required to sign a data access agreement.
Tipo de información de apoyo para compartir IPD
- Protocolo de estudio
- Plan de Análisis Estadístico (SAP)
- Formulario de consentimiento informado (ICF)
- Código analítico
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .